JP Morgan Upgrades CoreWeave to Overweight from Neutral
Fintel reports that on September 24, 2026, JP Morgan upgraded their outlook for CoreWeave (NASDAQGS:CRWV) (BIT:1CRWV) from Neutral to Overweight.
This rating action follows a prior action on August 12, 2026, when JP Morgan maintained its Neutral rating on the stock. Other analyst firms have also recently updated their coverage of CoreWeave. On September 23, 2026, UBS initiated coverage on the company with a Buy rating. On September 21, 2026, Rothschild & Co initiated coverage with a Sell rating. Additionally, Rosenblatt maintained its Buy rating on September 18, 2026.
CoreWeave's stock closed at $86.90 on September 23, 2026, which was also the pre-action close. This price represents a one-week price change of +4.26% from a baseline close of $83.35 on September 16, 2026. Over a one-month period, the stock saw a price change of -1.08% from a baseline close of $87.85 on August 21, 2026.
The company reported its latest earnings on August 11, 2026. CoreWeave posted an actual EPS of -1.03, compared to the estimated EPS of -1.2303. The actual revenue for the quarter was $2,575,000,000.00, which was below the estimated revenue of $2,611,109,097.00.
As of September 15, 2026, the current consensus target mean for CoreWeave was $146.88, with a median target of $153.00. This current mean target implies a change of +69.02%. The prior consensus target mean was $146.64 as of August 28, 2026, representing a consensus target revision of +0.17%.
In the current recommendation period of September 1, 2026, the consensus recommendation breakdown showed 46 total recommendations, with 69.6% positive, 26.1% hold, and 4.3% negative. Specifically, there were 10 strong buy, 22 buy, 12 hold, 1 sell, and 1 strong sell recommendations. In the prior period of August 1, 2026, there were 45 total recommendations, with 68.9% positive, 26.7% hold, and 4.4% negative, consisting of 10 strong buy, 21 buy, 12 hold, 1 sell, and 1 strong sell recommendations.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| September 24, 2026 | JP Morgan | Neutral | Overweight | upgrade |
| September 23, 2026 | UBS | Buy | initiated coverage | |
| September 21, 2026 | Rothschild & Co | Sell | initiated coverage | |
| September 18, 2026 | Rosenblatt | Buy | Buy | maintained |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.